Breakthrough study defines ideal interval for immunotherapy and liver transplants

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new cases and 830,200 deaths were registered in 2020 according to the World Health Organization.